http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2133720-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d7463c209152681d030f21b4c09659d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-559
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
filingDate 1994-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1acdd93d1f986c96dcc4090f1f4adf13
publicationDate 1999-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2133720-T3
titleOfInvention CYCLOPENTAN ACIDS (IN) HEPTENOIC OR HEPTANOIC AND DERIVED FROM THE SAME USEFUL AS THERAPEUTIC AGENTS.
abstract THE INVENTION REFERS TO HEPTANOIC OR HEPTENOIC ACIDS OF 7 - [5 - HYDROXY - 2 - (HYDROXYHYDROCARBYL OR HYDROCARBYL SUBSTITUTED WITH HETEROATOMES), 3-HYDROXYCHLOPENYL (PHENYL OENALS) AND HYDROXIDE GROUPS ARE REPLACED BY A GROUP OF ETER. THE COMPOUNDS OF THE INVENTION ARE POWERFUL EYE HYPOTENSIONERS, AND ARE PARTICULARLY SUITABLE FOR THE MANAGEMENT OF GLAUCOMA.
priorityDate 1993-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9253

Total number of triples: 35.